A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment

Summary

The main goal of this study is to evaluate the safety and tolerability of 40 or 80 mg atomoxetine as a treatment for cocaine dependence. The Phase I studies summarized above support the safety of atomoxetine in combination with stimulants. As the next step, the investigators will evaluate the safety and tolerability of atomoxetine in a small clinical trial with cocaine users. If atomoxetine is found to be promising in this study and sufficiently powered, double-blind, placebo-controlled studies will be proposed.

Timeline

Start

2012-12

Primary completion

2014-03

Completion

2014-03

Outcome

Outcome not reported

Stopped (Enrollment): “No funding stopped recruitment march 2014 with only 14 enrolled”

Drugs

Indications